Difficulty: Medium
Average Score: 87%
Practice
A patient receiving erythropoietin-stimulating drug has the following laboratory values: hemoglobin, 12.8 mg/dL; platelet count, 148,000/mm2; white blood cell count, 4800/mm2. Which action is most appropriate for the nurse to implement?
Correct answer
B
Rationale
The patient's hemoglobin level of 12.8 mg/dL is within the target range for erythropoietin therapy, which is typically 10-12 g/dL. The nurse should continue monitoring the patient and ensure that the hemoglobin does not exceed 12 g/dL, as higher levels can increase the risk of thromboembolic events. Administering additional erythropoietin is unnecessary and potentially harmful. Stopping the medication abruptly is not indicated unless directed by the healthcare provider. Colony-stimulating factors are used to increase white blood cell counts, not hemoglobin levels.